Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B, 9780443414138
Hardcover
Unlock cancer’s secrets: Biomarkers for diagnosis, prognosis, and treatment response.
Pre-Order

Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B

$608.76

  • Hardcover

    277 pages

  • Release Date

    1 October 2025

Check Delivery Options

Summary

Circulating Biomarkers in Cancer: Diagnosis, Prognosis, and Treatment Response - Part B

Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part B delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. Specific chapters in this new release include Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers, Identification of circu…

Book Details

ISBN-13:9780443414138
ISBN-10:0443414130
Series:International Review of Cell and Molecular Biology
Author:Lorenzo Galluzzi, Sheila Spada
Publisher:Elsevier Science Publishing Co Inc
Imprint:Academic Press Inc
Format:Hardcover
Number of Pages:277
Release Date:1 October 2025
Weight:450g
Dimensions:229mm x 152mm
About The Author

Lorenzo Galluzzi

Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.

Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.